M. Y. Wani

Novel carbazate derivatives impair Candidozyma auris immune evasion by β-1,3-glucan unmasking and disruption in metabolic reprogramming.

Identification of novel drug candidates against Candidozyma auris (C. auris), an emerging fungal pathogen associated with global healthcare outbreaks, is of considerable importance. A major clinical challenge in C. auris infection is its ability to evade host immune responses through distinct processes, including reduc...